Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z011862 | — |
No adverse event; Nurse reported that a 45-year-old patient received PROQUAD due to a human error. No additional AE/No PQC reported.; This spontaneous report was received from other health professional and refers to a 45-year-old patient of unknown gender (Inappropriate age at vaccine administration). The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 04-Dec-2025, the patient received the first dose of measles, mumps, rubella, and varicella (Oka-Merck) virus vaccine, live (PROQUAD), reconstituted with Hollister-Stier Sterile Diluent, for prophylaxis. The lot #Z011862 was verified as valid, with an expiration date of 13-Jan-2027 (dose, route of administration, and anatomical site of injection were not reported). The vaccination was reported as a human error. No additional adverse event was reported (no adverse event).
Sterile diluent